Welcome to Eurofins Advinus
A premier preclinical and development stage contract research company for regulatory Toxicology (Safety Assessment), CMC services, DMPK and Analytical R&D Services. With over 30 years of GLP compliance and certification, Eurofins Advinus serves diverse industries such as Biotech, Pharmaceutical, Biological, Agrochemical, Nutraceutical and Cosmetic. Eurofins Advinus is the only contract research organization (CRO) in India to have developed data in support of 70+ end-to-end IND enabling packages to be submitted to global regulators such as USFDA, EMA, MHRA, Health Canada and others.
Meet us at
Virtual
12th – 26th March 2021
EUROFINS ADVINUS' ACHIEVEMENTS
YEARS OF
GLP EXPERIENCE
IND PACKAGES
CARCINOGENICITY STUDIES
REGULATORY STUDIES
FACILITY TOUR
NEWS AND EVENTS
Eurofins announces acquisition of assets of Gomti Life Sciences
Eurofins, through Eurofins Advinus, acquires all assets of Gomti Life… more
Eurofins Advinus Diwali Celebration
Eurofins Advinus Diwali celebrations... rangoli and traditional wear add colour… more
Eurofins Advinus at BIO International Convention - 2019 , Philadelphia, USA
Eurofins Advinus at 2019 - BIO International Convention, Philadelphia, USA more
Eurofins is a 2019 CRO Award Winner
Eurofins has proudly been a winner of the CRO Leadership… more
CASE STUDIES - SEE HOW OUR SCIENCE CAN DRIVE YOUR RESEARCH & DEVELOPMENT
WHAT OUR CLIENTS SAY
-
Revere has had a…
Revere has had a first-rate and productive partnership with Eurofins Advinus, Bangalore, India for over 2 years. During this time, we have performed ADME/DMPK and IND safety assessment studies at Eurofins Advinus. The team was highly experienced, professional, and enthusiastic, providing scientific insights and communicating effectively, while addressing any technical challenges during the engagement period. Amid the COVID pandemic, all our timelines were met, and the quality of the data and reports were excellent. We are extremely pleased with the services provided by Eurofins Advinus for our preclinical drug development program and IND-enabling studies and would enthusiastically recommend their high-quality services to others.
Jedd Levine, Chief Medical Officer, Revere Pharmaceuticals, USA
-
The Eurofins Advinus team…
The Eurofins Advinus team has shown excellent performance in progressing the chemistry and delivering critical compounds which have helped us in advancing the project and answering very pertinent hypothesis to understand the SAR. The team deserves appreciation for meeting deliverables par excellence, even through the scale-up synthesis in a brief period with high quality and purity for advancing in-vivo-studies.
Dr. Shahul Hameed, Chief Product Officer, Bugworks Research Inc
-
We are happy to…
We are happy to work with the Eurofins Advinus team since the beginning of our project. We find professionalism, reactivity and proactivity in anticipating potential issues and resolving them in short time. The asset produced meets international standards of quality (non GMP and GMP).
Stephane Paris, Scientific R&D Project Manager, PMP, Accure Tx
-
We have had an…
We have had an excellent partnership with Eurofins Advinus for over 6 years. During this period, we have performed several IND enabling studies that were accepted by the regulatory agencies (US-FDA, HC, EMA) and these programs are currently undergoing PoC clinical trials. In addition, post IND we have conducted subchronic and chronic toxicity studies including genetic toxicity, DART and carcinogenicity studies each supported with excellent analytical and bioanalytical capabilities. We are extremely happy with the proficiency of the team and the quality of data meets the international standards. We are pleased with the services provided by Eurofins Advinus and look forward to our continued collaboration.
Dr. Mahesh Mistry, Director Toxicology